HEADER CELL ADHESION 14-APR-06 2DKS TITLE SOLUTION STRUCTURE OF THE FIRST IG-LIKE DOMAIN OF HUMAN TITLE 2 CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 8 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 8; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: V-SET DOMAIN; COMPND 5 SYNONYM: CARCINOEMBRYONIC ANTIGEN CGM6, NONSPECIFIC CROSS-REACTING COMPND 6 ANTIGEN NCA-95, CD67 ANTIGEN, CD66B ANTIGEN; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CEACAM8; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: P050620-05; SOURCE 8 OTHER_DETAILS: CELL FREE PROTEIN SYNTHESIS KEYWDS BETA-SANDWICH, IG-FOLD, CARCINOEMBRYONIC ANTIGEN CGM6, NONSPECIFIC KEYWDS 2 CROSS-REACTING ANTIGEN NCA-95, ANTIGEN CD67, CD66B ANTIGEN, KEYWDS 3 STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT ON PROTEIN STRUCTURAL KEYWDS 4 AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL GENOMICS/PROTEOMICS KEYWDS 5 INITIATIVE, RSGI, CELL ADHESION EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR K.NAGASHIMA,F.HAYASHI,M.YOSHIDA,S.YOKOYAMA,RIKEN STRUCTURAL AUTHOR 2 GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 4 29-MAY-24 2DKS 1 REMARK REVDAT 3 09-MAR-22 2DKS 1 REMARK SEQADV REVDAT 2 24-FEB-09 2DKS 1 VERSN REVDAT 1 01-MAY-07 2DKS 0 JRNL AUTH K.NAGASHIMA,F.HAYASHI,M.YOSHIDA,S.YOKOYAMA JRNL TITL SOLUTION STRUCTURE OF THE FIRST IG-LIKE DOMAIN OF HUMAN JRNL TITL 2 CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 8 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : VNMR 6.1C, CYANA 2.0.17 REMARK 3 AUTHORS : VARIAN (VNMR), GUNTERT, P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DKS COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-APR-06. REMARK 100 THE DEPOSITION ID IS D_1000025532. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 120MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.26MM 13C, 15N-LABELEDPROTEIN; REMARK 210 20MM D-TRIS-HCL(PH7.0); 100MM REMARK 210 NACL; 1MM D-DTT; 0.02% NAN3, 10% REMARK 210 D2O; 90% H2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_13C-SEPARATED_NOESY; 3D_15N REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 20031121, NMRVIEW 5.0.4, REMARK 210 KUJIRA 0.932, CYANA 2.0.17 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION, STRUCTURES WITH REMARK 210 THE LEAST RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: SPECTROMETER_ID 1 FOR 3D_13C-SEPARATED_NOESY; REMARK 210 SPECTROMETER_ID 2 FOR 3D_15N-SEPARATED_NOESY REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 3 -59.15 -131.59 REMARK 500 1 PRO A 17 -175.31 -69.73 REMARK 500 1 PRO A 37 94.18 -69.77 REMARK 500 1 VAL A 48 53.69 -94.84 REMARK 500 1 PRO A 78 2.28 -69.77 REMARK 500 1 ASN A 86 51.86 39.73 REMARK 500 1 VAL A 87 172.26 -57.37 REMARK 500 1 PRO A 117 88.04 -69.82 REMARK 500 1 PRO A 122 86.66 -69.78 REMARK 500 2 PRO A 17 -178.64 -69.80 REMARK 500 2 LEU A 33 160.37 -48.27 REMARK 500 2 PRO A 34 -177.14 -69.74 REMARK 500 2 PRO A 37 87.36 -69.80 REMARK 500 2 ARG A 38 -31.69 -36.91 REMARK 500 2 PRO A 78 2.29 -69.83 REMARK 500 2 VAL A 109 111.46 -161.58 REMARK 500 2 GLU A 118 80.92 -64.70 REMARK 500 2 PRO A 122 -169.47 -69.72 REMARK 500 2 PRO A 127 90.30 -69.75 REMARK 500 3 PRO A 34 -175.18 -69.78 REMARK 500 3 VAL A 48 56.57 -96.97 REMARK 500 3 ALA A 69 30.56 -84.10 REMARK 500 3 PRO A 78 2.32 -69.71 REMARK 500 3 VAL A 87 172.41 -58.35 REMARK 500 3 ASN A 103 31.62 -86.42 REMARK 500 3 LEU A 104 29.46 49.49 REMARK 500 3 PRO A 117 85.72 -69.81 REMARK 500 3 GLU A 118 38.92 -99.00 REMARK 500 3 PRO A 122 91.62 -69.78 REMARK 500 4 PRO A 17 -178.30 -69.80 REMARK 500 4 PRO A 34 -177.49 -69.80 REMARK 500 4 GLN A 62 46.18 34.14 REMARK 500 4 PRO A 78 2.47 -69.75 REMARK 500 4 ALA A 80 31.69 73.06 REMARK 500 4 LEU A 102 -18.01 -49.84 REMARK 500 4 VAL A 109 117.53 -160.69 REMARK 500 4 PRO A 117 87.91 -69.85 REMARK 500 4 GLU A 118 102.23 -43.22 REMARK 500 4 LYS A 121 118.76 -166.62 REMARK 500 4 PRO A 122 0.52 -69.76 REMARK 500 5 LEU A 33 158.97 -47.94 REMARK 500 5 PRO A 37 82.58 -69.72 REMARK 500 5 ARG A 38 -32.07 -35.98 REMARK 500 5 ARG A 53 106.59 -59.36 REMARK 500 5 ILE A 55 143.03 -171.18 REMARK 500 5 PRO A 78 2.82 -69.71 REMARK 500 5 ASN A 103 33.18 -83.95 REMARK 500 5 GLU A 118 100.87 -58.48 REMARK 500 5 SER A 128 106.20 -37.73 REMARK 500 6 GLU A 22 131.54 -39.31 REMARK 500 REMARK 500 THIS ENTRY HAS 201 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 2DKS A 8 124 UNP P31997 CEAM8_HUMAN 33 149 SEQADV 2DKS GLY A 1 UNP P31997 CLONING ARTIFACT SEQADV 2DKS SER A 2 UNP P31997 CLONING ARTIFACT SEQADV 2DKS SER A 3 UNP P31997 CLONING ARTIFACT SEQADV 2DKS GLY A 4 UNP P31997 CLONING ARTIFACT SEQADV 2DKS SER A 5 UNP P31997 CLONING ARTIFACT SEQADV 2DKS SER A 6 UNP P31997 CLONING ARTIFACT SEQADV 2DKS GLY A 7 UNP P31997 CLONING ARTIFACT SEQADV 2DKS SER A 125 UNP P31997 CLONING ARTIFACT SEQADV 2DKS GLY A 126 UNP P31997 CLONING ARTIFACT SEQADV 2DKS PRO A 127 UNP P31997 CLONING ARTIFACT SEQADV 2DKS SER A 128 UNP P31997 CLONING ARTIFACT SEQADV 2DKS SER A 129 UNP P31997 CLONING ARTIFACT SEQADV 2DKS GLY A 130 UNP P31997 CLONING ARTIFACT SEQRES 1 A 130 GLY SER SER GLY SER SER GLY THR ALA GLN LEU THR ILE SEQRES 2 A 130 GLU ALA VAL PRO SER ASN ALA ALA GLU GLY LYS GLU VAL SEQRES 3 A 130 LEU LEU LEU VAL HIS ASN LEU PRO GLN ASP PRO ARG GLY SEQRES 4 A 130 TYR ASN TRP TYR LYS GLY GLU THR VAL ASP ALA ASN ARG SEQRES 5 A 130 ARG ILE ILE GLY TYR VAL ILE SER ASN GLN GLN ILE THR SEQRES 6 A 130 PRO GLY PRO ALA TYR SER ASN ARG GLU THR ILE TYR PRO SEQRES 7 A 130 ASN ALA SER LEU LEU MET ARG ASN VAL THR ARG ASN ASP SEQRES 8 A 130 THR GLY SER TYR THR LEU GLN VAL ILE LYS LEU ASN LEU SEQRES 9 A 130 MET SER GLU GLU VAL THR GLY GLN PHE SER VAL HIS PRO SEQRES 10 A 130 GLU THR PRO LYS PRO SER ILE SER GLY PRO SER SER GLY HELIX 1 1 ASP A 49 ASN A 51 5 3 SHEET 1 A 4 THR A 12 VAL A 16 0 SHEET 2 A 4 VAL A 26 HIS A 31 -1 O LEU A 27 N VAL A 16 SHEET 3 A 4 LEU A 82 MET A 84 -1 O MET A 84 N VAL A 26 SHEET 4 A 4 GLU A 74 ILE A 76 -1 N THR A 75 O LEU A 83 SHEET 1 B 2 ASN A 19 ALA A 21 0 SHEET 2 B 2 SER A 114 HIS A 116 1 O HIS A 116 N ALA A 20 SHEET 1 C 5 GLN A 63 PRO A 66 0 SHEET 2 C 5 ARG A 53 VAL A 58 -1 N GLY A 56 O THR A 65 SHEET 3 C 5 PRO A 37 TYR A 43 -1 N TYR A 40 O TYR A 57 SHEET 4 C 5 LEU A 97 LYS A 101 -1 O GLN A 98 N ASN A 41 SHEET 5 C 5 MET A 105 SER A 106 -1 O MET A 105 N LYS A 101 CISPEP 1 VAL A 16 PRO A 17 1 -0.09 CISPEP 2 VAL A 16 PRO A 17 2 -0.03 CISPEP 3 VAL A 16 PRO A 17 3 -0.03 CISPEP 4 VAL A 16 PRO A 17 4 0.01 CISPEP 5 VAL A 16 PRO A 17 5 0.01 CISPEP 6 VAL A 16 PRO A 17 6 -0.07 CISPEP 7 VAL A 16 PRO A 17 7 0.03 CISPEP 8 VAL A 16 PRO A 17 8 -0.01 CISPEP 9 VAL A 16 PRO A 17 9 -0.05 CISPEP 10 VAL A 16 PRO A 17 10 -0.01 CISPEP 11 VAL A 16 PRO A 17 11 -0.06 CISPEP 12 VAL A 16 PRO A 17 12 -0.04 CISPEP 13 VAL A 16 PRO A 17 13 -0.06 CISPEP 14 VAL A 16 PRO A 17 14 -0.04 CISPEP 15 VAL A 16 PRO A 17 15 -0.07 CISPEP 16 VAL A 16 PRO A 17 16 -0.07 CISPEP 17 VAL A 16 PRO A 17 17 -0.07 CISPEP 18 VAL A 16 PRO A 17 18 -0.03 CISPEP 19 VAL A 16 PRO A 17 19 0.01 CISPEP 20 VAL A 16 PRO A 17 20 0.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1